Genentech | search
Click here to view Genentech news from 60+ newspapers.
Bookmark or Share- Press Releases - GenentechGenentech Announces Positive Phase III Results for Inavolisib Combination in People With Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer With a PIK3CA Mutation. 21 Nov 2023. Genentech and NVIDIA Enter Into Strategic AI Research Collaboration to Accelerate Drug Discovery and Development. 26 Oct 2023.
- GenentechBreakthrough science. One moment, one day, one person at a time.
- About Us - GenentechGenentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases. Our transformational discoveries include the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis.
- Careers at GenentechWe believe diversity and inclusion drives innovation and contributes to equitable healthcare access for all. At Genentech, different backgrounds and perspectives are essential. Improving patients’ lives is what we strive to do. Each of our 13,500+ employees, from scientists to marketers, advances our mission.
- Our Medicines & Products - GenentechFind important safety information and patient resources for all of our currently marketed medicines.
More
